Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 3 | BMC Medical Informatics and Decision Making

Fig. 3

From: A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients

Fig. 3

The comparison between the fourteen-lncRNA-based RFS classifier and clinicopathological features in all MIBC samples. a. Univariate Cox proportional-hazards regression analysis results of fourteen-lncRNA-based classifier and clinicopathological features, respectively. b. ROC curve of low- and high-risk sets verified by the fourteen-lncRNA-based classifier and clinicopathological features, respectively

Back to article page